CALLAN RAYMOND: Open Payments
NPI 1316665771 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 17 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $28 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $316 |
| Janssen Biotech, Inc. | 1 | $131 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Incyte Corporation | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
| Genmab U.S., Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
Products named: DARZALEX, KEYTRUDA, Nubeqa, Stivarga, Epkinly.
Industry payments across MD — which companies pay providers there.
